Microclinic International
7
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Micro-Clinic Obesity and Metabolic Risk Prevention Program
Role: lead
Microclinic Social Network Behavioral Health Trial in Jordan
Role: lead
The Kanyakla Study: a Microclinic Social Network Intervention for Promoting Engagement and Retention in HIV Care
Role: collaborator
Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar
Role: lead
Healthy Networks Water Treatment Study
Role: collaborator
Mfangano Island Healthy Networks Impact Study
Role: collaborator
Jordan Diabetes Microclinic Project
Role: lead
All 7 trials loaded